Genome-wide association study of determinants of anti-cyclic citrullinated peptide antibody titer in adults with rheumatoid arthritis

Molecular Medicine

Volumn 15, Issue 5-6, 2009, Pages 136-143

  Cui, Jing ^a   Taylor, Kimberly E ^b   DeStefano, Anita L ^c   Criswell, Lindsey A ^b   Izmailova, Elena S ^d   Parker, Alex ^d   Roubenoff, Ronenn ^e   Plenge, Robert M ^a,f   Weinblatt, Michael E ^a   Shadick, Nancy A ^a   Karlson, Elizabeth W ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BOSTON UNIVERSITY   (United States)

^d MILLENNIUM PHARMACEUTICALS INC   (United States)

^e BIOGEN   (United States)

^f BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; EPITOPE; HLA DR ANTIGEN; HLA DR3 ANTIGEN;

ADULT; ANTIBODY TITER; ARTICLE; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENOME ANALYSIS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ANTIBODIES; ARTHRITIS, RHEUMATOID; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HLA-DR ANTIGENS; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PEPTIDES, CYCLIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 66449088323     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2009.00008     Document Type: Article

References (27)

1. Gabriel SE, Crowson CS, O'Fallon WM. (1999) The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985. Arthritis Rheum. 42:415-20.
2. Jawaheer D, Gregersen PK. (2002) Rheumatoid arthritis. The genetic components. Rheum. Dis. Clin. North. Am. 28:1-15, v.
3. Newton JL, Harney SM, Wordsworth BP, Brown MA. (2004) A review of the MHC genetics of rheumatoid arthritis. Genes Immun. 5:151-7.
4. Jawaheer D, et al. (2003) Screening the genome for rheumatoid arthritis susceptibility genes: a replication study and combined analysis of 512 multicase families. Arthritis Rheum. 48:906-16.
5. Gregersen PK, Silver J, Winchester RJ. (1987) The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 30:1205-13.
6. Vallbracht I, et al. (2004) Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Ann. Rheum. Dis. 63:1079-84.
7. van Gaalen FA, et al. (2004) Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum. 50:2113-21.
8. Meyer O, et al. (2006) Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis. Arthritis Res. Ther. 8: R40.
9. Mierau R, Genth E. (2006) Diagnosis and prognosis of early rheumatoid arthritis, with special emphasis on laboratory analysis. Clin. Chem. Lab. Med. 44:138-43.
10. Berglin E, et al. (2006) Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset. Ann. Rheum. Dis. 65:453-8.
11. Huizinga TW, et al. (2005) Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum. 52:3433-8.
12. Karlson EW, et al. (2008) Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study. Ann. Rheum. Dis. 67:358-63.
13. Plenge RM, et al. (2007) Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat. Genet. 39:1477-82.
14. Ding B, et al. (2009) Different patterns of associations with anti-citrullinated protein antibody- positive and anti-citrullinated protein antibody- negative rheumatoid arthritis in the extended major histocompatibility complex region. Arthritis Rheum. 60:30-8.
15. Lee HS, et al. (2007) Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohorts. Arthritis Rheum. 56:1745-53.
16. Irigoyen P, et al. (2005) Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles. Arthritis Rheum. 52:3813-8.
17. van der Helm-van Mil AH, et al. (2006) The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. Arthritis Rheum. 54:1117-21.
18. van der Helm-van Mil AH, et al. (2007) The HLA-DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide. Arthritis Rheum. 56:425-32.
19. Shadick NA, et al. (2007) Opposing effects of the D70 mutation and the shared epitope in HLA- DR4 on disease activity and certain disease phe- notypes in rheumatoid arthritis. Ann. Rheum. Dis. 66:1497-502.
20. Purcell S, et al. (2007) PLINK: a tool set for whole-genome association and population- based linkage analyses. Am. J. Hum. Genet. 81:559-75.
21. Plenge RM, et al. (2007) TRAF1-C5 as a risk locus for rheumatoid arthritis - a genomewide study. N. Engl. J. Med. 357:1199-209.
22. Tian C, et al. (2008) Analysis and application of European genetic substructure using 300 K SNP information. PLoS Genetics 4:e4.
23. Barrett JC, Fry B, Maller J, Daly MJ. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-5.
24. Frazer KA, et al. (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature 449:851-61.
25. Remmers EF, et al. (2007) STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N. Engl. J. Med. 357:977-86.
26. Wellcome Trust Case Control Consortium, et al. (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447:661-78.
27. Raychaudhuri S, et al. (2008) Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat. Genet. 40:1216-23.